Growth.

For large pharma companies, such as Johnson & Johnson, a constant question is how it can carry on growing its pharmaceutical revenues. This very question has been asked by both competitors and investors recently – but it must be remembered that this year alone J&J has acquired Cougar Biotechnology and is moving to secure the non-US distribution rights to two major drugs from Schering – Plough… these major moves will ensure that J&J retains its place as a market leader…. 

By Simon Jacob